Powered by GoogleTranslate


General Description

  • Synonyms: Amethopterin; 4-Amino-l0-methylfolic acid; 1-Glutamic acid, N-(4-(((2,4-diamino-6-pteridinyl)methyl)methylamino))benzoyl; Glutamic acid, N-(p-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-, L; Methopterin; Amethopterine; HDMTX; MTX; L-N-(p-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl) Glutamic acid
  • OSHA IMIS Code Number: M106
  • Chemical Abstracts Service (CAS) Registry Number: 59-05-2
  • NIOSH Registry of Toxic Effects of Chemical Substances (RTECS) Identification Number: MA1225000
  • Chemical Description and Physical Properties:
    • bright yellow-orange, odorless, crystalline powder
    • molecular weight: 454.4
    • molecular formula: C20H22N8O5
    • melting point: 185-204°C (monohydrate)

Health Factors

  • Carcinogenic Classification:
  • Potential Symptoms: Nausea, vomiting, loss of appetite, weight loss; bloody diarrhea; sores inside the mouth; low white blood cell count; hair loss; skin rash; dry cough; liver and kidney damage
  • Health Effects: Reproductive hazard---Impaired fertility, Miscarriage, Teratogenesis (HE5); Immunosuppression (HE3)
  • Affected Organs: Blood, liver, kidneys, reproductive system
  • Notes:
    1. OSHA does not have a PEL for methotrexate.
    2. One case report indicated allergic contact dermatitis in a worker at a methotrexate manufacturer, which was attributed to cross-sensitivity with a precursor to methotrexate synthesis, 2,4-diamino-6-chloromethylpteridine HCl.
    3. Except for rare cases of allergic contact dermatitis, adverse health effects of occupational exposure to methotrexate have not been reported.
    4. Health effects, if any, of the increased incidence of genetic damage markers reported for workers (with unknown exposure levels) at a methotrexate production facility in China remain to be elucidated.
    5. Teratogenic effects (craniofacial and digital anomalies, growth retardation) have been described in offspring of pregnant women receiving methotrexate for cancer treatment or in attempts to induce abortion.
  • Literature Basis:
    • Bawle, E.V., Conard, J.V. and Weiss, L.: Adult and two children with fetal methotrexate syndrome. Teratology 57(2): 51-55, 1998.
    • Dastychová, E.: Allergic contact dermatitis in methotrexate manufacture. Contact Dermatitis 48(4): 226-227, 2003.
    • Deng, H., et al.: Investigating genetic damage in workers occupationally exposed to methotrexate using three genetic end-points. Mutagenesis 20(5): 351-357, 2005.
    • Izzedine, H., Launay-Vacher, V. Karie, S., Caramella, C., de Person, F. and Deray, G.: Is low-dose methotrexate nephrotoxic? Case report and review of the literature. Clin. Nephrol. 64(4): 315-319, 2005.
    • Kalantzis, A., Marshman, Z., Falconer, D.T., Morgan, P.R. and Odell E.W.: Oral effects of low-dose methotrexate treatment. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 100(1): 52-62, 2005.
    • Lateef, O., Shakoor, N. and Balk, R.A.: Methotrexate pulmonary toxicity. Expert Opin. Drug Saf. 4(4): 723-730, 2005.
    • Pohanish, R.P. (editor): Methotrexate. In, Sittig's Handbook of Toxic and Hazardous Chemicals and Carcinogens, Fourth Ed., Vol. 2. Norwich, NY: Noyes Publications, William Andrew Publishing, 2002, pp. 1504-1505.
    • Sessink, P.J., Friemel, N.S., Anzion, R.B. and Bos, R.P.: Biological and environmental monitoring of occupational exposure of pharmaceutical plant workers to methotrexate. Int. Arch. Occup. Environ. Health 65(6): 401-403, 1994.
  • Date Last Revised: 04/20/2006

Monitoring Methods used by OSHA

Primary Laboratory Sampling/Analytical Method (SLC1):
  • OSHA Versatile Sampler (OVS-2) 13 mm XAD-2 Tube (270/140 mg sections, 20/60 mesh) with Glass Fiber filter enclosed
  • analytical solvent: 0.4 M sodium carbonate in (75:25) water:methanol
  • maximum volume: 120 Liters
  • maximum flow rate: 1.0 L/min
  • current analytical method: High Performance Liquid Chromatography; HPLC/UV
  • method reference: OSHA Analytical Method (OSHA PV2146)
  • method classification: Partially Validated
Bulk Method:
  • Limit the amount of bulk submitted to one gram or one mL.

** All Trademarks are the property of their respective owners.

Back to Top

Thank You for Visiting Our Website

You are exiting the Department of Labor's Web server.

The Department of Labor does not endorse, takes no responsibility for, and exercises no control over the linked organization or its views, or contents, nor does it vouch for the accuracy or accessibility of the information contained on the destination server. The Department of Labor also cannot authorize the use of copyrighted materials contained in linked Web sites. Users must request such authorization from the sponsor of the linked Web site. Thank you for visiting our site. Please click the button below to continue.